Methamphetamine Enhances HIV-1 Replication in CD4 T-Cells Via a Novel IL-1β Auto-Regulatory Loop

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Mar 3

PMID 32117283

Citations 10

Authors

Kaycie S Lawson

Anil Prasad

Jerome E Groopman

Affiliations

Soon will be listed here.

Abstract

Methamphetamine (Meth) abuse is a worldwide public health problem and contributes to HIV-1 pathobiology and poor adherence to anti-retroviral therapies. Specifically, Meth is posited to alter molecular mechanisms to provide a more conducive environment for HIV-1 replication and spread. Enhanced expression of inflammatory cytokines, such as Interleukin-1β (IL-1β), has been shown to be important for HIV-1 pathobiology. In addition, microRNAs (miRNAs) play integral roles in fine-tuning the innate immune response. Notably, the effects of Meth abuse on miRNA expression are largely unknown. We studied the effects of Meth on IL-1β and miR-146a, a well-characterized member of the innate immune signaling network. We found that Meth induces miR-146a and triggers an IL-1β auto-regulatory loop to modulate innate immune signaling in CD4 T-cells. We also found that Meth enhances HIV-1 replication via IL-1 signaling. Our results indicate that Meth activates an IL-1β feedback loop to alter innate immune pathways and favor HIV-1 replication. These observations offer a framework for designing targeted therapies in HIV-infected, Meth using hosts.

Citing Articles

Neurological impact of HIV/AIDS and substance use alters brain function and structure.

Haorah J, Malaroviyam S, Iyappan H, Samikkannu T Front Med (Lausanne). 2025; 11:1505440.

PMID: 39839621 PMC: 11747747. DOI: 10.3389/fmed.2024.1505440.

Impact of HIV-1 tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 tat transgenic mice.

Zhu J, Cirincione A, Strauss M, Davis S, Eans S, Tribbitt D Eur J Pharmacol. 2024; 984:177030.

PMID: 39366503 PMC: 11563864. DOI: 10.1016/j.ejphar.2024.177030.

Single-cell RNA-seq Reveals the Inhibitory Effect of Methamphetamine on Liver Immunity with the Involvement of Dopamine Receptor D1.

Zhou J, Xu Y, Liu X, Cheng C, Fan J, Li X Genomics Proteomics Bioinformatics. 2024; 22(4).

PMID: 39196711 PMC: 11576359. DOI: 10.1093/gpbjnl/qzae060.

Interleukin-1β promotes human metapneumovirus replication via activating the cGAS-STING pathway.

Wu G, Zhang Y, Niu L, Hu Y, Yang Y, Zhao Y Virus Res. 2024; 343:199344.

PMID: 38431054 PMC: 10982080. DOI: 10.1016/j.virusres.2024.199344.

HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development.

Cook C, Craddock V, Ram A, Abraham A, Dhillon N Compr Physiol. 2023; 13(3):4659-4683.

PMID: 37358518 PMC: 10693986. DOI: 10.1002/cphy.c210049.

References

Soper A, Kimura I, Nagaoka S, Konno Y, Yamamoto K, Koyanagi Y . Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control. Front Immunol. 2018; 8:1823. PMC: 5775519. DOI: 10.3389/fimmu.2017.01823. View

Potula R, Hawkins B, Cenna J, Fan S, Dykstra H, Ramirez S . Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J Immunol. 2010; 185(5):2867-76. PMC: 3124898. DOI: 10.4049/jimmunol.0903691. View

Prasad A, Kuzontkoski P, Shrivastava A, Zhu W, Li D, Groopman J . Slit2N/Robo1 inhibit HIV-gp120-induced migration and podosome formation in immature dendritic cells by sequestering LSP1 and WASp. PLoS One. 2012; 7(10):e48854. PMC: 3485365. DOI: 10.1371/journal.pone.0048854. View

Quaranta M, Olivetta E, Sanchez M, Spinello I, Paolillo R, Arenaccio C . miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4(+) T lymphocytes. Virology. 2015; 478:27-38. DOI: 10.1016/j.virol.2015.01.016. View

Peerzada H, Gandhi J, Guimaraes A, Nosanchuk J, Martinez L . Methamphetamine administration modifies leukocyte proliferation and cytokine production in murine tissues. Immunobiology. 2013; 218(8):1063-8. PMC: 5589440. DOI: 10.1016/j.imbio.2013.02.001. View

Prasad A, Kulkarni R, Shrivastava A, Jiang S, Lawson K, Groopman J . Methamphetamine functions as a novel CD4 T-cell activator via the sigma-1 receptor to enhance HIV-1 infection. Sci Rep. 2019; 9(1):958. PMC: 6353873. DOI: 10.1038/s41598-018-35757-x. View

Gonzales R, Mooney L, Rawson R . The methamphetamine problem in the United States. Annu Rev Public Health. 2010; 31:385-98. PMC: 4440680. DOI: 10.1146/annurev.publhealth.012809.103600. View

Mata M, Napier T, Graves S, Mahmood F, Raeisi S, Baum L . Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse. Eur J Pharmacol. 2015; 752:26-33. PMC: 4396630. DOI: 10.1016/j.ejphar.2015.02.002. View

Ellis R, Childers M, Cherner M, Lazzaretto D, Letendre S, Grant I . Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003; 188(12):1820-6. DOI: 10.1086/379894. View

10.

Djuranovic S, Nahvi A, Green R . miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science. 2012; 336(6078):237-40. PMC: 3971879. DOI: 10.1126/science.1215691. View

11.

Kawai T, Akira S . Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007; 13(11):460-9. DOI: 10.1016/j.molmed.2007.09.002. View

12.

Toussi S, Joseph A, Zheng J, Dutta M, Santambrogio L, Goldstein H . Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res Hum Retroviruses. 2009; 25(11):1117-21. PMC: 2828189. DOI: 10.1089/aid.2008.0282. View

13.

Turowski P, Kenny B . The blood-brain barrier and methamphetamine: open sesame?. Front Neurosci. 2015; 9:156. PMC: 4419855. DOI: 10.3389/fnins.2015.00156. View

14.

Lodish H, Zhou B, Liu G, Chen C . Micromanagement of the immune system by microRNAs. Nat Rev Immunol. 2008; 8(2):120-30. DOI: 10.1038/nri2252. View

15.

Baxter A, Russell R, Duncan C, Moore M, Willberg C, Pablos J . Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe. 2014; 16(6):711-21. PMC: 4271767. DOI: 10.1016/j.chom.2014.10.010. View

16.

King C, Kobayashi T, Cejas P, Kim T, Yoon K, Kim G . TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med. 2006; 12(9):1088-92. DOI: 10.1038/nm1449. View

17.

Nair M, Saiyed Z . Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells. Life Sci. 2010; 88(21-22):987-94. PMC: 3044785. DOI: 10.1016/j.lfs.2010.09.019. View

18.

Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I . Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011; 34(2):213-23. DOI: 10.1016/j.immuni.2011.02.006. View

19.

Wie S, Du P, Luong T, Rought S, Beliakova-Bethell N, Lozach J . HIV downregulates interferon-stimulated genes in primary macrophages. J Interferon Cytokine Res. 2013; 33(2):90-5. PMC: 3573720. DOI: 10.1089/jir.2012.0052. View

20.

Massanella M, Gianella S, Schrier R, Dan J, Perez-Santiago J, Oliveira M . Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015; 5:13179. PMC: 4547398. DOI: 10.1038/srep13179. View